Roivant Sciences Ltd. (ROIV)
41.43
+6.50
(+18.61%)
USD |
NASDAQ |
Sep 08, 15:59
41.30
-0.13
(-0.31%)
After-Hours: 20:00
Roivant Sciences Gross Profit Margin (Quarterly) : 38.70% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 38.70% |
| March 31, 2026 | 61.98% |
| December 31, 2025 | 30.42% |
| September 30, 2025 | 34.31% |
| June 30, 2025 | 42.30% |
| March 31, 2025 | 79.02% |
| December 31, 2024 | 75.58% |
| September 30, 2024 | 94.77% |
| June 30, 2024 | 36.22% |
| March 31, 2024 | 75.11% |
| December 31, 2023 | 82.55% |
| September 30, 2023 | 93.89% |
| Date | Value |
|---|---|
| June 30, 2023 | 56.98% |
| March 31, 2023 | 65.71% |
| December 31, 2022 | 51.18% |
| September 30, 2022 | 70.95% |
| June 30, 2022 | 60.04% |
| March 31, 2022 | 95.02% |
| December 31, 2021 | 94.31% |
| September 30, 2021 | 54.38% |
| June 30, 2021 | 90.41% |
| March 31, 2021 | 96.84% |
| March 31, 2020 | 99.06% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Oxford Biomedica Plc | -- |
| Bicycle Therapeutics Plc | -69.64% |
| Arbutus Biopharma Corp. | 98.92% |
| Moderna, Inc. | -7.59% |
| Adaptimmune Therapeutics Plc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.36% |
| Return on Assets | -7.87% |
| Return on Invested Capital | -8.18% |
| Profit Margin (Quarterly) | -20.15K% |
| Operating Margin (Quarterly) | -25.41K% |
| Return on Net Operating Assets | -421.0% |